Update on extracorporeal photochemotherapy for graft-versus-host disease treatment

J. Kanold, C. Messina, P. Halle, Franco Locatelli, E. Lanino, S. Cesaro, F. Deméocq

Risultato della ricerca: Contributo in rivistaArticolo in rivista


Pediatric experience with extracorporeal photochemotherapy (ECP) for graft-versus-host disease (GvHD) has mainly been reported by Italian and French groups. Data concerning 41 children with acute GvHD and 63 children affected by chronic GvHD are available. In 73 and 63% of them, respectively, improvement was observed, with addition of ECP to their immunosuppressive regimen. Treatment with ECP was associated with minimal side effects, even in the smallest of patients. In all responded pediatric patients, both with acute and chronic GvHD, ECP allowed progressive reduction or discontinuation of the concomitant pharmacological immunosuppressive therapy without an increase in GvHD acitivity. These data show that ECP is a useful therapy for children affected by GvHD resistant to conventional treatment and can be safely used.
Lingua originaleEnglish
pagine (da-a)69-71
Numero di pagine3
RivistaBone Marrow Transplantation
Volume35 Suppl 1
Stato di pubblicazionePubblicato - 2005


  • extracorporeal photochemotherapy
  • graft-versus-host disease
  • children


Entra nei temi di ricerca di 'Update on extracorporeal photochemotherapy for graft-versus-host disease treatment'. Insieme formano una fingerprint unica.

Cita questo